<code id='A1D29BBDF6'></code><style id='A1D29BBDF6'></style>
    • <acronym id='A1D29BBDF6'></acronym>
      <center id='A1D29BBDF6'><center id='A1D29BBDF6'><tfoot id='A1D29BBDF6'></tfoot></center><abbr id='A1D29BBDF6'><dir id='A1D29BBDF6'><tfoot id='A1D29BBDF6'></tfoot><noframes id='A1D29BBDF6'>

    • <optgroup id='A1D29BBDF6'><strike id='A1D29BBDF6'><sup id='A1D29BBDF6'></sup></strike><code id='A1D29BBDF6'></code></optgroup>
        1. <b id='A1D29BBDF6'><label id='A1D29BBDF6'><select id='A1D29BBDF6'><dt id='A1D29BBDF6'><span id='A1D29BBDF6'></span></dt></select></label></b><u id='A1D29BBDF6'></u>
          <i id='A1D29BBDF6'><strike id='A1D29BBDF6'><tt id='A1D29BBDF6'><pre id='A1D29BBDF6'></pre></tt></strike></i>

          explore

          explore

          author:fashion    Page View:1
          James Fanale, the former CEO and president of Care New England, and his wife Deb (left) on their front porch. -- health coverage from STAT
          Courtesy Ryan Pickering

          PROVIDENCE – In late August, Dr. James E. Fanale was trudging through the Falmouth Road Race — walking up the hills, running down them — for seven miles. Fellow runners encouraged him to “keep trying” whenever he slowed down. But they couldn’t have known — along with most of the people in Fanale’s professional orbit — that he was battling Stage 4 lung cancer.

          “Many times, I wanted to say ‘Listen buddy, you don’t know what I’ve got in me,’” Fanale recalled recently with a chuckle.

          advertisement

          In December 2022, on the day Fanale retired as president and CEO of Care New England, he shared his diagnosis with a Globe reporter but requested it be kept private. He was handing the reins to new CEO Dr. Michael Wagner after six years leading the second largest health care system in Rhode Island.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          'Patient friction coefficient' can gauge a clinical trial's patient burden
          'Patient friction coefficient' can gauge a clinical trial's patient burden

          AdobeTherigorandcomplexityneededtogeneratemeasurableresultsfromclinicaltrialsoftenmakesthemdifficult

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          How to improve immunocompromised access to mAb treatments

          Monoclonalantibodiesfightagroupofcoronaviruscellsina3Drendering.AdobeAstheU.S.grappleswiththelasting